Circulating Tumor Cells in Gastrointestinal Malignancies: Current Techniques and Clinical Implications

Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer

(2009) S. J. Cohen et al.   ANNALS OF ONCOLOGY

Detection of KRAS Oncogene in Peripheral Blood as a Predictor of the Response to Cetuximab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer

(2009) L.-C. Yen et al.   CLINICAL CANCER RESEARCH

Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer

(2009) H. Schwarzenbach et al.   CLINICAL CANCER RESEARCH

Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome

(2009) Andreas-Claudius Hoffmann et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Dihydropyrimidine dehydrogenase mRNA expression in peripheral blood of rectal cancer patients is significantly associated with residual tumor and distant metastases following resection

(2009) Andreas-Claudius Hoffmann et al.   JOURNAL OF SURGICAL ONCOLOGY

Analysis of Circulating Tumor DNA to Confirm Somatic KRAS Mutations

(2009) Matthias Holdhoff et al.   JNCI-Journal of the National Cancer Institute

Thymidylate synthase gene variations: predictive and prognostic markers

(2009) G. Lurje et al.   MOLECULAR CANCER THERAPEUTICS

Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer

(2009) Georg Lurje et al.   Pharmacogenetics and Genomics

Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer

(2008) G. Lurje et al.   ANNALS OF ONCOLOGY

Clinical Significance of Circulating Tumor Cells in Blood from Patients with Gastrointestinal Cancers

(2008) Kunihiko Hiraiwa et al.   ANNALS OF SURGICAL ONCOLOGY

Polymorphisms in Cyclooxygenase-2 and Epidermal Growth Factor Receptor Are Associated with Progression-Free Survival Independent of K-ras in Metastatic Colorectal Cancer Patients Treated with Single-Agent Cetuximab

(2008) G. Lurje et al.   CLINICAL CANCER RESEARCH

Circulating Tumor Cells and Bone Marrow Micrometastasis

(2008) C. Alix-Panabieres et al.   CLINICAL CANCER RESEARCH

Stem Cells in Colon Cancer

(2008) Alexandra Pohl et al.   Clinical Colorectal Cancer

KRASMutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

(2008) Astrid Lièvre et al.   JOURNAL OF CLINICAL ONCOLOGY

Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer

(2008) Steven J. Cohen et al.   JOURNAL OF CLINICAL ONCOLOGY

ERCC1 RNA Expression in Peripheral Blood Predicts Minor Histopathological Response to Neoadjuvant Radio-chemotherapy in Patients with Locally Advanced Cancer of the Esophagus

(2008) Jan Brabender et al.   JOURNAL OF GASTROINTESTINAL SURGERY

The “seed and soil” hypothesis revisited

(2008) Isaiah J Fidler et al.   LANCET ONCOLOGY

Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer

(2008) Georg Lurje et al.   Pharmacogenetics and Genomics